If you or someone you love uses Dupixent, you may have recently seen television ads or online headlines linking the medication to rare forms of cancer. For many patients, this has caused confusion, fear, and frustration, especially for those who finally found relief after years of severe eczema or asthma.
This guide is not intended to cause panic. We want to help increase awareness and patient empowerment.
At Morris James, we regularly speak with people who feel caught in the middle—still relying on a medication their doctor prescribed, while wondering whether they were fully informed about its risks. Understanding what is known, what is alleged, and what practical steps you can take can help you protect both your health and your rights.
Dupixent is not being accused of being “toxic” or unsafe for everyone. The lawsuits currently being filed across the country make a more specific claim: Patients allege that the manufacturers failed to adequately warn doctors and users about a potential increased risk of a rare cancer called Cutaneous T-Cell Lymphoma (CTCL).
CTCL is a slow-growing cancer of the immune system that often appears first on the skin. What makes this issue especially concerning is that CTCL can closely resemble eczema, with red, scaly, itchy patches that may come and go. Medical authorities have long recognized that CTCL is frequently misdiagnosed in its early stages because of these similarities.
Recent medical publications and patient case reports have raised concerns that Dupixent’s ability to reduce inflammation may temporarily improve the appearance of these patches, potentially delaying a correct diagnosis. This concept is sometimes referred to as “masking.”
It is important to understand that:
However, patients have the right to know about emerging safety concerns so they can be properly monitored. For a deeper discussion of these issues, you may wish to read our article: Can Dupixent Cause Lymphoma? What Patients and Families Should Know.
Because CTCL can look so much like eczema, early warning signs are often missed. Be alert and do not ignore anything that catches your attention or feels “different” from your typical flare.
Consult your dermatologist as soon as possible if anything concerns you. Some common red flags include:
These symptoms do not automatically mean cancer. But they are often cited as reasons why a skin biopsy may be appropriate. Additional common questions are addressed in Dupixent Lawsuits for T-Cell Lymphoma FAQs.
Many patients are uncomfortable asking their doctor for answers or explanations when they are concerned or confused. You are allowed—and encouraged—to advocate for yourself.
It can help to say something as simple as:
“I’ve been reading about Dupixent and skin cancers that can mimic eczema. I’d like a full-body skin exam today, and I want to keep an eye on this specific area. If it doesn’t improve, can we discuss a biopsy?”
A biopsy is a routine procedure and remains the most reliable way to rule out CTCL.
Most importantly, do not stop taking Dupixent without medical guidance. Abruptly stopping a medication can have severe consequences.
Whether or not you are experiencing symptoms, simple recordkeeping can help support both your medical care and any future legal claim. Consider keeping a simple health and medication log that covers:
If you are wondering whether your situation may qualify for legal review, “Who Is Eligible to File a Dupixent Lymphoma Lawsuit? Understanding Criteria, Timing, and Next Steps” provides additional context.
Many Dupixent patients reaching out to law firms are not looking to sue immediately. They want answers. They want to know whether they should be concerned and whether they were given all the information they deserved.
Product liability cases like these focus on one central question: Were patients adequately warned so they could make informed medical decisions? If the answer is no, the law allows injured individuals to seek compensation for medical costs, lost income, and the physical and emotional toll of delayed diagnosis. This is part of a broader area of law known as failure-to-warn claims. Read more about failure-to-warn claims in Injured by a Prescription Drug? What You Need to Know About Pharmaceutical Lawsuits and Failure to Warn Claims.
No one should feel embarrassed or frightened for trusting a prescribed medication. Dupixent has helped many people reclaim their quality of life. At the same time, patients deserve transparency, proper screening, and timely warnings when new risks emerge.
If you have been diagnosed with CTCL after using Dupixent, contact our attorneys for a free, confidential consultation. We handle these cases on a contingency basis, meaning there is no legal fee unless we recover compensation for you.
Call 302.655.2599 or contact us online to discuss your concerns and learn how we can help you protect your health and your rights.
No one should feel embarrassed or frightened for trusting a prescribed medication....patients deserve transparency, proper screening, and timely warnings when new risks emerge.
